Making FIT Count: Maximizing Appropriate Use of the Fecal Immunochemical Test for Colorectal Cancer Screening Programs.

Journal of General Internal Medicine
Vivy T Cusumano, Folasade P May

Abstract

Colorectal cancer (CRC) remains one of the most common and deadly malignancies despite advancements in screening, diagnostic capabilities, and treatment. The ability to detect and remove precancerous and cancerous lesions via screening has altered the epidemiology of the disease, decreasing incidence, mortality, and late-stage disease presentation. The fecal immunochemical test (FIT) is a screening test that aims to detect human hemoglobin in the stool. FIT is the most common CRC screening modality worldwide and second most common in the United States. Its use in screening programs has been shown to increase screening uptake and improve CRC outcomes. However, FIT-based screening programs vary widely in quality and effectiveness. In health systems with high-quality FIT screening programs, only superior FIT formats are used, providers order FIT appropriately, annual patient participation is high, and diagnostic follow-up after an abnormal result is achieved in a timely manner. Proper utilization of FIT involves multiple steps beyond provider recommendation of the test. In this commentary, we aim to highlight ongoing challenges in FIT screening and suggest interventions to maximize FIT effectiveness. Through active engagement of p...Continue Reading

References

Jun 16, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Deborah A FisherKenneth Fasanella
Dec 25, 2007·Journal of General Internal Medicine·Ann C DeBourcyThomas D Denberg
Jan 9, 2009·Journal of General Internal Medicine·Sandhya K RaoThomas D Sequist
Feb 5, 2009·Annals of Internal Medicine·Sabrina HundtHermann Brenner
Oct 13, 2010·Archives of Internal Medicine·Charlotte M CarlsonLouise C Walter
Jul 9, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Deepa NaishadhamAhmedin Jemal
Nov 24, 2011·The American Journal of Gastroenterology·Aafke H C van RoonMonique E van Leerdam
Feb 24, 2012·The New England Journal of Medicine·Enrique QuinteroUNKNOWN COLONPREV Study Investigators
Mar 20, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Sergio CrottaCarlo Senore
Apr 12, 2012·Archives of Internal Medicine·John M InadomiRodney A Hayward
Oct 2, 2012·European Journal of Gastroenterology & Hepatology·Anne F van RijnEvelien Dekker
May 28, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Hermann Brenner, Sha Tao
Sep 21, 2013·The New England Journal of Medicine·Aasma ShaukatTimothy R Church
Dec 10, 2013·Gastroenterology·Charles J KahiThomas F Imperiale
Jan 24, 2014·Frontiers in Pharmacology·Miren B ZuberoLuis Bujanda
Mar 25, 2014·Annals of Internal Medicine·Jeffrey K LeeDouglas A Corley
May 17, 2014·American Journal of Public Health·Jeanette M DalyCamden P Bay
Jun 25, 2014·Journal of Medical Screening·Barcey T LevyCarol Moss
Jan 7, 2015·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jan 27, 2016·Annals of Internal Medicine·Christopher D JensenPauline A Mysliwiec
Feb 5, 2016·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jessica ChubakUNKNOWN PROSPR consortium
Feb 15, 2016·Journal of Community Health·Ann OluloroGloria D Coronado
Mar 20, 2016·British Journal of Anaesthesia·S HeschlM Rigaud
May 24, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Reinier G S MeesterIris Lansdorp-Vogelaar
Jun 16, 2016·JAMA : the Journal of the American Medical Association·UNKNOWN US Preventive Services Task ForceAlbert L Siu
Jun 16, 2016·JAMA : the Journal of the American Medical Association·Jennifer S LinEvelyn P Whitlock
Dec 7, 2016·British Journal of Cancer·Manon van der VlugtEvelien Dekker
Jan 12, 2017·Journal of the American Board of Family Medicine : JABFM·Chyke A DoubeniTheodore R Levin
Feb 6, 2017·The American Journal of Gastroenterology·Rachel B IssakaMa Somsouk
Apr 27, 2017·JAMA : the Journal of the American Medical Association·Douglas A CorleyTheodore R Levin
May 17, 2017·United European Gastroenterology Journal·Esmée J GrobbeeManon Cw Spaander
May 31, 2017·The American Journal of Gastroenterology·Douglas K RexDouglas J Robertson
Jun 15, 2017·World Journal of Gastroenterology : WJG·Mercedes NavarroAngel Lanas
Oct 11, 2017·The American Journal of Gastroenterology·Jean A ShapiroMarion R Nadel
Oct 11, 2017·The American Journal of Gastroenterology·Jason A DominitzPeter D Guarino
Oct 20, 2017·Annals of Internal Medicine·Kevin SelbyDouglas A Corley

❮ Previous
Next ❯

Citations

May 28, 2020·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Caitlin C MurphyAmit G Singal
Apr 4, 2021·Cancers·Enea FerlizzaMattia Lauriola
Apr 28, 2021·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·John S LuqueClement K Gwede

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.